Balovaptan
| CAS No. | 1228088-30-9 | Cat. No. | BCP28931 |
| Name | Balovaptan | ||
| Synonyms | RG7314; RG 7314; RG-7314; | ||
| Formula | C22H24ClN5O | M. Wt | 409.92 |
| Description | Balovaptan, also known as RG7314, is a vasopressin receptor antagonist. Balovaptan has shown potential as a treatment for people with autism spectrum disorder (ASD). Balovaptan has shown the potential to improve social interaction and communication in people with ASD. Balovaptan is an investigational small molecule currently in clinical development by Roche for the treatment of ASD. It acts as a vasopressin (V1a) receptor antagonist. | ||
| Pathways | GPCR/G Protein | ||
| Targets | Vasopressin Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.